Charles Elliott Sigal - 22 May 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Sung Lee, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
22 May 2023
Net transactions value
$0
Form type
4
Filing time
24 May 2023, 14:33:48 UTC
Previous filing
19 May 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6,027 +62% $0.000000 15,806 22 May 2023 Direct
holding VIR Common Stock 10,000 22 May 2023 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12,054 $0.000000 12,054 22 May 2023 Common Stock 12,054 $25.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By Sigal Family Investments, LLC